Sharon Brownlow is a seasoned commercial leader in the biotech and cell and gene therapy industry, boasting over 20 years of experience. They served as Business Development Manager at Cobra Biologics from 2012 to 2017 and played pivotal roles at Applikon Biotechnology UK and Sartorius Stedim Biotech earlier in their career. At the Cell and Gene Therapy Catapult from 2017 to 2020, Sharon led collaborations to enhance global research partnerships, and they currently hold Non-Executive Director positions at Cytomos and ArcticZymes Technologies ASA. Sharon earned a BSc in Biophysics from the University of East Anglia and a PhD in Protein Crystallography from the University of Leeds.
This person is not in the org chart
This person is not in any teams
This person is not in any offices